| Literature DB >> 27493721 |
Erik P Rönmark1, Linda Ekerljung1, Roxana Mincheva1, Sigrid Sjölander2, Stig Hagstad1, Göran Wennergren3, Eva Rönmark4, Jan Lötvall1, Bo Lundbäck1.
Abstract
BACKGROUND: Atopic diseases including asthma, rhinitis and eczema have increased in the second half of the past century. This has been well studied among children and adolescents but with the exception of asthma to a much lesser extent in adults. The adult risk factor pattern of atopic diseases, in particular of eczema, and their relation to allergic sensitization are yet to be fully elucidated. Studies among adults that have compared the risk factor pattern for these conditions in the same material are very few. The objective of this study was to compare the risk factor patterns for asthma, rhinitis and eczema in a randomly selected adult population.Entities:
Keywords: Asthma; Eczema; Epidemiology; Population study; Prevalence; Rhinitis; Risk factors
Year: 2016 PMID: 27493721 PMCID: PMC4973051 DOI: 10.1186/s13601-016-0112-0
Source DB: PubMed Journal: Clin Transl Allergy ISSN: 2045-7022 Impact factor: 5.871
Fig. 1Map of Sweden depicting the geographic area of West Sweden where the study was conducted
Fig. 2Flowchart of the study design and participation
Baseline characteristics of the studied population
| Age (years) | Sex | |||||||
|---|---|---|---|---|---|---|---|---|
| 18–39 | 40–59 | 60–77 | P value1 | Men | Women | P value2 | Total (95 % CI) | |
| Current asthma | 12.3 | 13.4 | 9.4 | 0.216 | 10.1 | 13.2 | 0.122 | 11.8 (9.9–13.6) |
| Asthma ever | 17.8 | 16.2 | 11.8 | 0.024 | 14.0 | 16.2 | 0.328 | 15.2 (13.1–17.3) |
| Current rhinitis | 48.8 | 43.8 | 36.6 | 0.001 | 44.5 | 41.4 | 0.314 | 42.8 (40.0–45.7) |
| Rhinitis ever | 53.7 | 48.5 | 39.5 | <0.001 | 50.0 | 44.4 | 0.060 | 47.0 (44.2–50.0) |
| Current eczema | 12.9 | 17.0 | 9.7 | 0.167 | 11.3 | 15.4 | 0.040 | 13.5 (11.5–15.4) |
| Eczema ever | 49.1 | 46.8 | 38.2 | 0.003 | 36.5 | 51.6 | <0.001 | 44.6 (41.8–47.5) |
| Asthma medication 12 m | 11.0 | 12.5 | 10.7 | 0.864 | 9.8 | 13.0 | 0.098 | 11.5 (9.7–13.4) |
| Rhinitis medication 12 m | 33.7 | 30.8 | 19.9 | <0.001 | 27.1 | 28.9 | 0.515 | 28.1 (25.5–30.6) |
| Allergic sensitization | 40.9 | 31.0 | 18.6 | <0.001 | 36.0 | 24.2 | <0.001 | 29.7 (27.0–32.4) |
|
| ||||||||
| Never smoker | 70.6 | 52.1 | 49.5 | <0.001 | 58.5 | 54.5 | 0.015 | 56.4 (53.5–59.2) |
| Ex-smoker | 11.0 | 29.7 | 37.6 | 28.3 | 26.0 | 27.1 (24.5–29.6) | ||
| Current smoker | 18.4 | 18.2 | 12.9 | 13.1 | 19.5 | 16.5 (14.4–18.7) | ||
|
| ||||||||
| Asthma | 23.8 | 20.2 | 15.0 | 0.004 | 15.8 | 22.6 | 0.004 | 19.5 (17.2–21.8) |
| Rhinitis | 42.9 | 35.2 | 14.0 | <0.001 | 25.3 | 35.3 | <0.001 | 30.6 (27.9–33.4) |
| Asthma and rhinitis | 16.7 | 12.6 | 4.7 | <0.001 | 7.9 | 14.1 | 0.002 | 11.2 (9.4–13.1) |
| Asthma or rhinitis | 49.8 | 42.1 | 24.0 | <0.001 | 32.9 | 43.1 | <0.001 | 38.4 (35.6–41.2) |
|
| ||||||||
| Underweight (<20) | 10.4 | 3.0 | 1.0 | <0.001 | 1.5 | 7.0 | <0.001 | 4.4 (3.3–5.6) |
| Normal (20–25) | 54.9 | 34.7 | 28.0 | 33.2 | 42.4 | 38.1 (35.4–40.9) | ||
| Overweight (25–30) | 26.1 | 45.0 | 52.4 | 50.7 | 34.8 | 42.2 (39.3–45.0) | ||
| Obese (>30) | 8.6 | 17.2 | 18.6 | 14.6 | 15.9 | 15.3 (13.2–17.3) | ||
| Occupational GDF | 24.3 | 24.6 | 25.3 | 0.750 | 36.2 | 14.9 | <0.001 | 24.7 (22.3–27.2) |
| Metropolitan domicile | 70.6 | 50.9 | 52.4 | <0.001 | 54.8 | 58.6 | 0.214 | 57.0 (54.0–60.0) |
| Raised on a farm | 7.7 | 11.8 | 19.9 | <0.001 | 13.9 | 12.8 | 0.604 | 13.3 (11.4–15.3) |
Prevalence (%) and difference (p value) by sex and age group. Total prevalence with 95 % confidence intervals (95 % CI)
1Test for trend
2Fishers exact two sided test
3Pearson chi2 test for in group difference
Fig. 3Circular Venn diagram illustrating the prevalence of current rhinitis, current asthma and current eczema; and the overlap between the conditions
Crude odds ratios (OR) and 95 % confidence intervals (CI) for current asthma, current rhinitis and current eczema
| Independent variables | Dependent variables | ||
|---|---|---|---|
| Current asthma | Current rhinitis | Current eczema | |
| OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | |
|
| |||
| 60–77 | 1 | 1 | 1 |
| 40–59 | 1.48 (0.96–2.29) | 1.34 (1.02–1.77) | 1.91 (1.26–2.90) |
| 18–39 | 1.34 (0.83–2.17) | 1.65 (1.22–2.22) | 1.38 (0.86–2.20) |
|
| |||
| Men | 1 | 1 | 1 |
| Women | 1.34 (0.94–1.93) | 0.88 (0.70–1.11) | 1.45 (1.05–2.00) |
|
| |||
| Never smoker | 1 | 1 | 1 |
| Ex-smoker | 0.86 (0.56–1.31) | 0.96 (0.73–1.26) | 1.28 (0.87–1.89) |
| Current smoker | 1.04 (0.64–1.70) | 1.15 (0.83–1.59) | 1.46 (0.93–2.28) |
|
| |||
| None | 1 | 1 | 1 |
| Asthma | 1.33 (0.58–3.05) | 0.72 (0.42–1.25) | 1.44 (0.72–2.85) |
| Rhinitis | 1.49 (0.88–2.51) | 3.05 (2.20–4.24) | 1.32 (0.83–2.08) |
| Both | 5.41 (3.38–8.64) | 3.32 (2.23–4.95) | 1.82 (1.10–3.00) |
|
| |||
| Rural area (<500 inh.) | 1 | 1 | 1 |
| Village (500–2000 inh.) | 0.88 (0.29–2.65) | 1.23 (0.65–2.37) | 0.97 (0.35–2.74) |
| Small town (2000–10,000 inh.) | 1.28 (0.55–3.00) | 1.01 (0.58–1.75) | 1.16 (0.51–2.68) |
| Larger town (>10,000 inh.) | 1.29 (0.67–2.48) | 1.41 (0.94–2.11) | 1.39 (0.74–2.61) |
| Occupational exposure to GDF | |||
| No | 1 | 1 | 1 |
| Yes | 1.70 (1.16–2.49) | 1.10 (0.84–1.44) | 1.73 (1.21–2.48) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 0.86 (0.60–1.23) | 1.03 (0.81–1.30) | 1.21 (0.86–1.70) |
|
| |||
| Normal | 1 | 1 | 1 |
| Underweight | 1.17 (0.47–2.88) | 1.34 (0.75–2.38) | 1.24 (0.56–2.78) |
| Overweight | 1.07 (0.71–1.63) | 0.94 (0.73–1.22) | 0.98 (0.67–1.44) |
| Obese | 2.10 (1.29–3.40) | 1.79 (1.26–2.53) | 1.43 (0.89–2.31) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 4.02 (2.76–5.84) | 5.77 (4.34–7.67) | 1.35 (0.94–1.93) |
Crude odds ratios (OR) and 95 % confidence intervals (CI) for current asthma, current rhinitis and current eczema
| Independent variables | Dependent variables | ||
|---|---|---|---|
| Current asthma | Current rhinitis | Current eczema | |
| OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 0.84 (0.48–1.45) | 0.54 (0.38–0.78) | 0.45 (0.24–0.85) |
|
| |||
| 0 | 1 | 1 | 1 |
| 1 | 3.06 (1.29–7.25) | 1.37 (0.92–2.06) | 0.76 (0.45–1.29) |
| 2 or more | 2.76 (1.17–6.49) | 1.32 (0.89–1.97) | 0.59 (0.35–0.99) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 1.14 (0.80–1.63) | 1.40 (1.11–1.77) | 1.48 (1.06–2.07) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 1.05 (0.73–1.50) | 0.91 (0.72–1.15) | 1.52 (1.06–2.16) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 0.70 (0.35–1.37) | 1.04 (0.70–1.54) | 1.89 (1.13–3.14) |
|
| |||
| Yes | 1 | 1 | 1 |
| No | 1.19 (0.83–1.70) | 1.05 (0.75–1.49) | 1.24 (0.98–1.57) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 2.35 (1.57–3.51) | 0.94 (0.73–1.23) | 1.34 (0.92–1.94) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 1.22 (0.85–1.76) | 0.91 (0.72–1.16) | 0.99 (0.70–1.39) |
|
| |||
| 3000–4000 g | 1 | 1 | 1 |
| Less than 2500 g | 2.00 (0.89–4.50) | 1.22 (0.65–2.31) | 0.96 (0.39–2.35) |
| 2500–3000 g | 1.41 (0.81–2.45) | 1.04 (0.71–1.52) | 1.21 (0.73–1.99) |
| More than 4000 g | 0.72 (0.36–1.44) | 0.89 (0.60–1.31) | 0.54 (0.28–1.04) |
|
| |||
| Secondary school or less | 1 | 1 | 1 |
| High school | 1.00 (0.59–1.67) | 1.10 (0.79–1.54) | 1.49 (0.91–2.43) |
| University | 1.09 (0.67–1.78) | 1.15 (0.84–1.58) | 1.13 (0.69–1.84) |
Adjusted risk factors for current asthma, current rhinitis and current eczema
| Independent variables | Dependent variables | ||
|---|---|---|---|
| Current asthma | Current rhinitis | Current eczema | |
| OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | |
|
| |||
| 60–77 | 1 | 1 | 1 |
| 40–59 | 1.00 (0.61–1.63) | 0.88 (0.64–1.23) | 1.51 (0.95–2.38) |
| 18–39 | 0.73 (0.39–1.37) | 0.92 (0.61–1.41) | 0.88 (0.49–1.57) |
|
| |||
| Men | 1 | 1 | 1 |
| Women | 1.77 (1.15–2.70) | 0.91 (0.69–1.21) | 1.71 (1.17–2.51) |
|
| |||
| None | 1 | 1 | 1 |
| Asthma | 1.29 (0.55–3.04) | 0.61 (0.34–1.10) | 1.45 (0.72–2.94) |
| Rhinitis | 1.16 (0.66–2.03) | 2.58 (1.79–3.72) | 1.25 (0.77–2.04) |
| Both | 4.33 (2.57–7.30) | 2.76 (1.77–4.31) | 1.61 (0.94–2.76) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 1.85 (1.20–2.87) | 1.03 (0.76–1.41) | 2.08 (1.40–3.08) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 0.96 (0.52–1.77) | 0.64 (0.42–0.96) | 0.51 (0.27–0.99) |
|
| |||
| Normal | 1 | 1 | 1 |
| Underweight | 0.95 (0.36–2.55) | 1.42 (0.74–2.71) | 1.00 (0.44–2.30) |
| Overweight | 1.04 (0.65–1.67) | 1.04 (0.77–1.41) | 1.02 (0.68–1.54) |
| Obese | 1.95 (1.13–3.36) | 2.30 (1.53–3.46) | 1.34 (0.80–2.24) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 4.11 (2.71–6.25) | 5.11 (3.77–6.93) | 1.26 (0.85–1.85) |
|
| |||
| 0 | 1 | 1 | 1 |
| 1 | 3.09 (1.25–7.63) | 1.16 (0.74–1.81) | 0.72 (0.42–1.24) |
| 2 or more | 2.51 (1.02–6.15) | 1.15 (0.74–1.79) | 0.55 (0.32–0.94) |
|
| |||
| No | 1 | 1 | 1 |
| Yes | 0.92 (0.59–1.44) | 1.11 (0.81–1.52) | 1.40 (0.94–2.10) |
Risk is expressed in odds ratios (OR) with 95 % confidence intervals (CI)